Recent & repeated insider buying. Company expanding cancer trial with $PFE palbociclib & will report full dataset in Q2 2020. Trading below cash.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
